May 9, 2014

One thing remains unchanged about our nurse practitioner and physician assistant readers: Retail clinicians tend to love their jobs.

January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

July 24, 2014

The Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), a long-acting opioid analgesic.

July 23, 2014

Mylan on Wednesday announced that U.S. District Court for the district of New Jersey granted a temporary restraining order against Apotex Inc. and Apotex Corp. relating to Paroxetine CR.

July 22, 2014

The Food and Drug Administration has granted tentative approval to Teva Pharmaceutical for abacavir sulfate and lamivudine tablets, according to agency records.

July 17, 2014

Purdue Pharma announced that the Food and Drug Administration approved a new 7.5-mcg/hour dosage strength of Butrans (buprenorphine) transdermal system CIII.

July 17, 2014

Mylan on Thursday announced that the U.S. District Court for the district of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline in relation to paroxetine CR, the generic version of GSK's Paxil CR.

July 16, 2014

Daddy & Co. has created a new baby care line dubbed Daddy’s All Natural Health and Skincare.

July 16, 2014

Infirst Healthcare on Wednesday announced the introduction of three new chocolate-flavored cough-cold items called Dr. Cocoa.

July 15, 2014

Giant Eagle last week added prescription blood-pressure medications lisinopril and lisinopril HCTZ to the list of several antibiotics that the chain provides for free to its patients, according to a report in the Columbus Dispatch

July 14, 2014

CVS/pharmacy has introduced its new radiance PLATINUM brand of preservative-free vitamins and supplements.

July 14, 2014

Newcomer SOBO Skin Care has announced the release of a complete line of anti-aging skin care products including a wrinkle cream containing resveratrol.

July 14, 2014

Upsher-Smith Labs on Monday announced the launch of topiramate extended-release capsules, an authorized generic version of Qudexy XR (topiramate) extended-release capsules.

July 10, 2014

Alliance Labs on Wednesday announced the launch of DocuSol Kids, a non-irritating constipation solution. 

July 10, 2014

Personal care brand SheaMoisture has broadened its portfolio with new formulas made especially for babies and children with allergies and sensitive skin, including gluten and fragrance intolerance.

July 8, 2014

Greenstone, a U.S.-based subsidiary of Pfizer, announced the introduction of doxazosin mesylate tablets.

July 8, 2014

Mylan announced the launch of telmisartan tablets USP, which is used to treat hypertension.

July 8, 2014

Purdue Pharma on Tuesday announced that the Food and Drug Administration has granted priority review designation for the company's once-daily, single-entity hydrocodone bitartrate tablet. 

July 7, 2014

Sandoz announced the launch of valsartan tablets, an authorized generic version of Diovan tablets which is used for the treatment of high blood pressure.

July 3, 2014

Roche on Wednesday announced that Genentech, a member of the Roche Group, has entered into a definitive agreement to acquire Seragon Pharmaceuticals, a privately held biotechnology company based in San Diego. 

July 2, 2014

Health care providers wrote 259 million prescriptions for opioid painkillers in 2012 — many more in some states than in others — according to a Vital Signs report released Tuesday by the Centers for Disease Control and Prevention that highlights the danger of overdose.

July 2, 2014

Actavis on Wednesday announced that its subsidiary Forest Labs has successfully completed its acquisition of Furiex Pharmaceuticals in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug, following approval.

July 2, 2014

This Fourth of July, Prilosec OTC is paying tribute to the troops and thanking those who support this country by helping to bring back Fort Bragg’s Independence Day fireworks and celebration.

June 30, 2014

Actavis on Monday confirmed that it has filed an abbreviated new drug application with the Food and Drug Administration to market buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablets.